ArticleJMIR AI2026
Prediction of Type 2 Diabetes Mellitus From Chest X-Rays Using a Suite of Previously Developed Chronic Disease Deep Learning Models in an Ethnically Diverse Cohort: Observational Study.
Article in JMIR AI, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundScreening for type 2 diabetes (T2D) is not optimal, leading to a large number of patients being undiagnosed. Recently, deep learning (DL) applied to chest radiographs (CXRs) has shown promise for opportunistic T2D prediction. A prior study in a predominantly suburban non-Hispanic White cohort achieved an area under the curve (AUC) of 0.84 for prevalence. In this study, we evaluate the performance and generalizability of this DL model in an urban cohort with greater racial diversity, higher social deprivation, and higher T2D prevalence. We further assess whether integrating DL predictions with BMI and demographic variables improves T2D prediction beyond demographics and BMI alone.
objectiveThis study aims to externally validate a previously developed DL-based CXR model for T2D prediction in a diverse urban population, to assess its performance for both prevalent and incident T2D, and to determine whether combining DL predictions with demographics and BMI improves predictive performance.
methodsWe studied adults (2010-2020) from a tertiary academic medical center in Chicago with at least one ambulatory CXR. First, we performed external validation of a previously developed DL-CXR model by applying it directly to our cohort. Second, we evaluated whether combining the DL model output with additional data, demographics, BMI, and social deprivation index improved the performance. T2D prevalence was modeled using extreme gradient boosting, while incidence was assessed with Cox proportional hazards models. Model performance was compared using AUC and concordance, and feature contributions were evaluated using feature importance and odds ratios.
resultsAmong 39,908 patients (n=21,311, 53.4% non-Hispanic Black; n=9179, 23% Latino; and n=5587, 14% non-Hispanic White), 26% (n=10,376) had T2D at their first CXR. The previously developed DL-T2D model maintained discrimination for prevalent T2D in this diverse urban cohort, with similar performance across racial groups (Latino: 0.818; non-Hispanic White: 0.819; non-Hispanic Black: 0.790), supporting generalizability. Adding DL output to demographics and BMI improved prediction compared with clinical variables alone (AUC 0.808 vs 0.766; P<.001). For a 3-year incident T2D, the full model achieved an AUC of 0.709 with concordance of 0.707; individuals in the highest risk quartile had a 7-fold higher incidence.
conclusionsIn a diverse urban cohort, a previously developed DL model applied to CXRs provided significant incremental value beyond demographics and BMI for T2D risk prediction. Despite substantial differences in population characteristics compared with the derivation cohort, the DL model remained effective for T2D screening. Incidence prediction was less accurate than prevalence, highlighting the need for further refinement, potentially incorporating hemoglobin A
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.